CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 58.61 CNY -0.41%
Market Cap: 9.5B CNY

Intrinsic Value

The intrinsic value of one CanSino Biologics Inc stock under the Base Case scenario is 64.29 CNY. Compared to the current market price of 58.61 CNY, CanSino Biologics Inc is Undervalued by 9%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
64.29 CNY
Undervaluation 9%
Intrinsic Value
Price
Base Case Scenario

Valuation History
CanSino Biologics Inc

CanSino Biologics Inc
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for CanSino Biologics Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

CanSino Biologics Inc
SSE:688185
CN
Pharmaceuticals
Market Cap
9.5B CNY
IPO
Mar 28, 2019
CN
Pharmaceuticals
Market Cap
9.5B CNY
IPO
Mar 28, 2019
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CanSino Biologics Inc?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about CanSino Biologics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
CanSino Biologics Inc

Current Assets 4.4B
Cash & Short-Term Investments 3.3B
Receivables 687.3m
Other Current Assets 398.8m
Non-Current Assets 3.6B
Long-Term Investments 166m
PP&E 2.5B
Intangibles 264.7m
Other Non-Current Assets 698.9m
Efficiency

Free Cash Flow Analysis
CanSino Biologics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
CanSino Biologics Inc

Revenue
748.5m CNY
Cost of Revenue
-241.7m CNY
Gross Profit
506.8m CNY
Operating Expenses
-1.2B CNY
Operating Income
-667.8m CNY
Other Expenses
-52.4m CNY
Net Income
-720.1m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

CanSino Biologics Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional Revenue Growth Forecast
Positive Gross Profit
Exceptional 1-Year Revenue Growth
36/100
Profitability
Score

CanSino Biologics Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

CanSino Biologics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Negative Net Debt
60/100
Solvency
Score

CanSino Biologics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
CanSino Biologics Inc

Wall Street analysts forecast CanSino Biologics Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CanSino Biologics Inc is 67.67 CNY with a low forecast of 54.54 CNY and a high forecast of 82.61 CNY.

Lowest
Price Target
54.54 CNY
7% Downside
Average
Price Target
67.67 CNY
15% Upside
Highest
Price Target
82.61 CNY
41% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CanSino Biologics Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

News

Other Videos
What is the Intrinsic Value of one CanSino Biologics Inc stock?

The intrinsic value of one CanSino Biologics Inc stock under the Base Case scenario is 64.29 CNY.

Is CanSino Biologics Inc stock undervalued or overvalued?

Compared to the current market price of 58.61 CNY, CanSino Biologics Inc is Undervalued by 9%.

Back to Top